
What does this company do?
Rubicon Research Limited, established in 1999, is a pharmaceutical formulation company focused on innovation through research and development, with a strong presence in regulated markets, particularly the United States.The company operates two R&D facilities inspected by the USFDA (United States Food and Drug Administr…
Issue parameters, key dates and structure.
Material risk factors to consider before applying.
Rubicon Research Limited, established in 1999, is a pharmaceutical formulation company focused on innovation through research and development, with a strong presence in regulated markets, particularly the United States.The company operates two R&D facilities inspected by the USFDA (United States Food and Drug Administration) in India and Canada, along with two manufacturing plants in India. It holds accreditations from global regulatory bodies like the USFDA, WHO-GMP (World Health Organisation – Good Manufacturing Practices), and Health Canada. Rubicon’s portfolio includes 55 commercialised formulations in the U.S., highlighting its focus on regulated markets. Discuss on Trading Q&A
⚠️ This is not investment advice. CheckIPO provides information for educational purposes only. Always consult a SEBI-registered financial advisor before investing.
Key milestones from opening to listing.